Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NU206: Phase I start

In 1H08, NUVO will begin a dose-escalation

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE